-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The conclusions suggest that people with the BDNF gene variant Val/Val are more likely to have altered cognitive activity through transcranial magnetic stimulation (TMS)
Source: University of Barcelona
The gene for brain-derived neurotrophic factor (BDNF) has been implicated in a number of processes related to memory and brain plasticity
The article, published in the journal Scientific Reports, was led by Kilian Abellaneda, a researcher at the Barcelona Brain Stimulation Laboratory (BBSLab), and David Bartrés-Faz, a professor at the Faculty of Medicine and Health Sciences and a researcher at the Institute of Neuroscience at the University of Barcelona (UBNeuro).
TMS is a non-invasive technique that facilitates a better understanding of brain activity and has multiple applications in the study of cognitive processes and neuropsychological rehabilitation
"We believe that the data obtained in this study provide relevant information on the neurobiological mechanisms involved in neuroplasticity processes that explain individual differences in the effects of stimulation at the cognitive level
This research is part of the European collaborative Pharmacog project in the field of neurodegenerative diseases
article title
BDNF Val66Met gene polymorphism modulates brain activity following rTMS?induced memory impairment
